Vincerx Pharma Inc (VINC): Not A Time To Panic Nor Freeze
Vincerx Pharma Inc (VINC) concluded trading on Thursday at a closing price of $0.14, with 3.99 million shares of worth about $0.56 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -79.30% during that period and on January 16, 2025 the price saw a […]
Vincerx Pharma Inc (VINC) Volatility Spurs A Quest For Clarity
Currently, there are 31.40M common shares owned by the public and among those 25.70M shares have been available to trade. The company’s stock has a 5-day price change of -6.19% and -71.68% over the past three months. VINC shares are trading -83.56% year to date (YTD), with the 12-month market performance down to -78.58% lower. […]
Vincerx Pharma Inc (NASDAQ: VINC): Hunting Genuine Value In Market Debris
Currently, there are 21.24M common shares owned by the public and among those 13.41M shares have been available to trade. Insiders at the company have transacted a total of 6 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 6 of these insider trades were purchases, […]
Reviewing The Case For Vincerx Pharma Inc (VINC) Going Higher
Sage Rhino Capital LLC recently announced the acquisition of new stake in Vincerx Pharma Inc (NASDAQ:VINC). The institutional investor has increased its shareholding in the Healthcare company by 0.98% to 1.7 million shares with purchase of 16476.0 shares. This fresh investment now brings its stake to 7.97% valued currently at $1.11 million. In addition, BofA […]
